Inhibikase Therapeutics Inc
NASDAQ:IKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
US |
|
BRF SA
NYSE:BRFS
|
BR |
|
S
|
S & P Syndicate PCL
SET:SNP
|
TH |
Intrinsic Value
The intrinsic value of one
IKT
stock under the Base Case scenario is
0.06
USD.
Compared to the current market price of 1.68 USD,
Inhibikase Therapeutics Inc
is
Overvalued by 97%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Inhibikase Therapeutics Inc.
The intrinsic value of one
IKT
stock under the Base Case scenario is
0.06
USD.
Compared to the current market price of 1.68 USD,
Inhibikase Therapeutics Inc
is
Overvalued by 97%.